Cheng Sohanya Roshan — SEC Form 4 filings
SEC reporting owner CIK 1865796. 12 Form 4 filings on record with FilingPulse; latest filed 2026-05-15.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-25 to 2026-05-15. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 6 filings — 41,003 shares, $105,708 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 11.
- Largest priced transaction: sale of 4,604 shares @ $9.41 ($43,321) in Karyopharm Therapeutics Inc., filed 2026-03-03.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Karyopharm Therapeutics Inc. (KPTI) | EVP & Chief Commercial Officer | 11 | — | 7 legs · 41,003 sh · $105,708 | 10 |
| Carisma Therapeutics Inc. (CARM) | Director | 1 | — | — | 1 |
Form 4 filings — Cheng Sohanya Roshan
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-15 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 947 @ $0 · Sale (S): 324 @ $9.50 | EDGAR |
| 2026-03-03 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 4,604 @ $9.41 | EDGAR |
| 2026-02-03 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 32,415 @ $0 | EDGAR |
| 2025-10-16 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 43,650 @ $0 | EDGAR |
| 2025-09-16 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 945 @ $0 · Sale (S): 325 @ $6.43 | EDGAR |
| 2025-03-06 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 3,445 @ $6.29 | EDGAR |
| 2025-03-04 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 5,416 @ $0 · Grant/award (A): 4,583 @ $0 · Grant/award (A): 10,833 (derivative) @ $0 · Grant/award (A): 9,166 (derivative) @ $0 | EDGAR |
| 2024-11-01 | 4 | Carisma Therapeutics Inc. (CARM) | Grant/award (A): 38,700 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 5,356 @ $0.72 | EDGAR |
| 2024-03-04 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Sale (S): 21,840 @ $1.17 · Sale (S): 5,109 @ $1.20 | EDGAR |
| 2024-02-29 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 198,959 @ $0 | EDGAR |
| 2024-01-25 | 4 | Karyopharm Therapeutics Inc. (KPTI) | Grant/award (A): 14,167 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1865796 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →